Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2008: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
Research Abstract |
PI3K/AKT signaling pathway is activated in lymphatic endothelial cells in human lymphangioma tissue. Inhibitors for PI3K/AKT were applied to human lymphangioma derived lymphatic endothelial cells (HL-LECs) for apoptosis assay, failing to see any specific reaction in vitro. Five primary HL-LECs were established and transplanted to immunodeficient NOG mice, resulting in lymphangioma-like cystic tissue formation in all cases.
|